Emergency Medicine Doctors in Ridley Park, PA Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Tamika King, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 175 East Chester Pike, Taylor Hospital, Ridley Park, PA 19078 Phone: 610-595-6000    Fax: 610-617-6280

Dr. Cynthia Elizabeth Lee, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 175 E Chester Pike, Taylor Hospital, Ridley Park, PA 19078 Phone: 610-595-6458

Gregory Cuculino, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 East Chester Pike, Taylor Hospital, Ridley Park, PA 19078 Phone: 610-595-6000    Fax: 610-617-6280

Michael Dumin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 East Chester Pike, Taylor Hospital, Ridley Park, PA 19078 Phone: 610-595-6000    Fax: 610-617-6280

Melissa T Burkhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 175 East Chester Pike, Ridley Park, PA 19078 Phone: 610-595-6480

Dr. Suzanna Isabelle Hutchinson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 175 East Chester Pike, Ridley Park, PA 19078 Phone: 610-393-6458

News Archive

New research provides new hope for liver transplant patients with recurring hepatitis C

New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).

Radiologists develop new non-surgical post-mortem technique

A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.

Esperance completes EP 100 and paclitaxel Phase 2 combination trial on advanced ovarian cancer

Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.

The 31st ESTRO congress and the World Congress of Brachytherapy

ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients.

Air emissions near natural gas drilling sites may contribute to health problems

In a new study, researchers from the Colorado School of Public Health have shown that air pollution caused by hydraulic fracturing or fracking may contribute to acute and chronic health problems for those living near natural gas drilling sites.

Read more Medical News

› Verified 5 days ago